Ayala Pharma
IPO News: Filed S-1: Ayala Pharmaceuticals Files $50mm IPO
Ayala Pharma

Ayala Pharmaceuticals

NASDAQ:  AYLA

Size (mm):  $50.0

Bookrunners:  Citi | Jefferies

Co-Managers:  Oppenheimer | Raymond James

Major Holders:  Israel Biotech Fund | aMoon | Harel Insurance Company | Bristol-Meyers-Squib | Novartis Institutes for BioMedical Research

Description:  Ayala is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations.

Note:  Emerging Growth Company

 

Reference Link:  S-1